These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of advanced cancer of the cervix with transperineal interstitial irradiation. Aristizabal SA; Surwit EA; Hevezi JM; Heusinkveld RS Int J Radiat Oncol Biol Phys; 1983 Jul; 9(7):1013-7. PubMed ID: 6863068 [TBL] [Abstract][Full Text] [Related]
4. High dose rate transperineal interstitial brachytherapy for cervical cancer: high pelvic control and low complication rates. Demanes DJ; Rodriguez RR; Bendre DD; Ewing TL Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):105-12. PubMed ID: 10477013 [TBL] [Abstract][Full Text] [Related]
5. Carcinoma of the cervix stage IB: results of treatment with radiation therapy. Montana GS; Fowler WC; Varia MA; Walton LA; Kirsch M; Halle JS; McCafferty BB Int J Radiat Oncol Biol Phys; 1983 Jan; 9(1):45-9. PubMed ID: 6841175 [TBL] [Abstract][Full Text] [Related]
6. High dose-rate brachytherapy for elderly patients with uterine cervical cancer. Chen SW; Liang JA; Yang SN; Lin FJ Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465 [TBL] [Abstract][Full Text] [Related]
7. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Perez CA; Grigsby PW; Castro-Vita H; Lockett MA Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767 [TBL] [Abstract][Full Text] [Related]
8. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362 [TBL] [Abstract][Full Text] [Related]
9. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens. Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435 [TBL] [Abstract][Full Text] [Related]
10. High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients. Lorvidhaya V; Tonusin A; Changwiwit W; Chitapanarux I; Srisomboon J; Wanwilairat S; Chawapun N; Sukthomya V Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1185-91. PubMed ID: 10725630 [TBL] [Abstract][Full Text] [Related]
12. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2). Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794 [TBL] [Abstract][Full Text] [Related]
13. An analysis of the severe complications of irradiation of carcinoma of the uterine cervix: treatment with intracavitary radium and parametrial irradiation. Unal A; Hamberger AD; Seski JC; Fletcher GH Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):999-1004. PubMed ID: 6795161 [No Abstract] [Full Text] [Related]
14. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix. Chaney AW; Eifel PJ; Logsdon MD; Morris M; Wharton JT Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):113-8. PubMed ID: 10477014 [TBL] [Abstract][Full Text] [Related]
15. Radiation therapy alone in the treatment of carcinoma of uterine cervix. I. Analysis of tumor recurrence. Perez CA; Breaux S; Madoc-Jones H; Bedwinek JM; Camel HM; Purdy JA; Walz BJ Cancer; 1983 Apr; 51(8):1393-402. PubMed ID: 6402291 [TBL] [Abstract][Full Text] [Related]
16. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme. Wang CJ; Leung SW; Chen HC; Sun LM; Fang FM; Changchien CC; Huang EY; Wu JM; Chen CC Int J Radiat Oncol Biol Phys; 1997 May; 38(2):391-8. PubMed ID: 9226328 [TBL] [Abstract][Full Text] [Related]
18. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Perez CA; Grigsby PW; Chao KS; Mutch DG; Lockett MA Int J Radiat Oncol Biol Phys; 1998 May; 41(2):307-17. PubMed ID: 9607346 [TBL] [Abstract][Full Text] [Related]
19. Parametrial implant in Stage III B cancer of the cervix. III. A five-year study. Prempree T Cancer; 1983 Aug; 52(4):748-50. PubMed ID: 6861110 [TBL] [Abstract][Full Text] [Related]
20. Treatment of locally advanced cancer of the cervix with transperineal interstitial irradiation. Report on 106 cases. Aristizabal SA; Surwit E; Valencia A; Hevezi J Am J Clin Oncol; 1983 Dec; 6(6):645-50. PubMed ID: 6637876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]